» Articles » PMID: 29577941

How and Why Do Gastrointestinal Peptides Influence Food Intake?

Overview
Journal Physiol Behav
Date 2018 Mar 27
PMID 29577941
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the ability of some gastrointestinal hormones to reliably reduce meal size when administered prior to a meal, it is not understood why the repeated administration or genetic knockout of these hormones appear largely ineffective in reducing food intake and body weight. Here, we review evidence that the ability of GI peptides such as cholecystokinin (CCK) to elicit satiation is a consequence of prior learning. Evidence includes first, that the ability of some of these signals to modify food intake depends upon past experience and is malleable with new experience. Additionally, the ability of CCK and other gut signals to reduce food intake may not be hard-wired; i.e., any so-called "satiation" signal that reduces food intake in a single-meal situation may not continue to do so over repeated trials. The individual will respond to the signal only so long as it provides reliable information about caloric content. If a particular signal becomes unreliable, the individual will rely on other signals to end meals. Thus, gut peptides/hormones have important metabolic effects such as mediating absorption, digestion, and many aspects of the distribution of ingested nutrients throughout the body; and, if they have been reliably associated with natural stimuli that mediate satiation, they also inform behavior.

Citing Articles

Investigating the impact of microbiome-changing interventions on food decision-making: MIFOOD study protocol.

Vartanian M, Endres K, Lee Y, Friedrich S, Meemken M, Schamarek I BMC Nutr. 2025; 11(1):8.

PMID: 39806493 PMC: 11727427. DOI: 10.1186/s40795-024-00971-6.


Hunger, Satiety, and Their Vulnerabilities.

Stevenson R, Boutelle K Nutrients. 2024; 16(17).

PMID: 39275328 PMC: 11397003. DOI: 10.3390/nu16173013.


Examining the Potential Applicability of Orexigenic and Anorexigenic Peptides in Veterinary Medicine for the Management of Obesity in Companion Animals.

Osiak-Wicha C, Kras K, Tomaszewska E, Muszynski S, Arciszewski M Curr Issues Mol Biol. 2024; 46(7):6725-6745.

PMID: 39057043 PMC: 11275339. DOI: 10.3390/cimb46070401.


Distribution of cionin, a cholecystokinin/gastrin family peptide, and its receptor in the central nervous system of Ciona intestinalis type A.

Taniguchi S, Nakayama S, Iguchi R, Sasakura Y, Satake H, Wada S Sci Rep. 2024; 14(1):6277.

PMID: 38491056 PMC: 10942981. DOI: 10.1038/s41598-024-55908-7.


Elevated Fasting Satiety-Promoting Cholecystokinin (CCK) in Avoidant/Restrictive Food Intake Disorder Compared to Healthy Controls.

Murray H, Becker K, Harshman S, Breithaupt L, Kuhnle M, Dreier M J Clin Psychiatry. 2022; 83(5).

PMID: 35830620 PMC: 9801687. DOI: 10.4088/JCP.21m14111.


References
1.
Woods S, DAlessio D . Central control of body weight and appetite. J Clin Endocrinol Metab. 2008; 93(11 Suppl 1):S37-50. PMC: 2585760. DOI: 10.1210/jc.2008-1630. View

2.
Scrocchi L, Brown T, MacLusky N, Brubaker P, AUERBACH A, Joyner A . Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med. 1996; 2(11):1254-8. DOI: 10.1038/nm1196-1254. View

3.
Woods S, Strubbe J . The psychobiology of meals. Psychon Bull Rev. 2013; 1(2):141-55. DOI: 10.3758/BF03200770. View

4.
Garcia J, KIMELDORF D, KOELLING R . Conditioned aversion to saccharin resulting from exposure to gamma radiation. Science. 1955; 122(3160):157-8. View

5.
Maclusky N, Cook S, Scrocchi L, Shin J, Kim J, Vaccarino F . Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology. 2000; 141(2):752-62. DOI: 10.1210/endo.141.2.7326. View